Health and Me

Itisha Arya

New FDA Approved Medicine Offers Hormone-Free Relief From Menopause Sweats

new fda approved medicine

The US Food and Drug Administration has given the green light to a new once-daily pill that works without hormones to ease moderate to severe hot flashes in menopausal women, Bayer announced Friday. The drug, called elinzanetant, will be available in the US starting in November under the brand name <span>Lynkuet</span>, according to Bayer. 

It works by targeting brain chemicals responsible for hot flashes and night sweats, medically referred to as vasomotor symptoms. Experts estimate that over 80% of women experience hot flashes during <span>menopause</span>.

“This <span>FDA</span> approval marks a bold leap forward, our first non-hormonal treatment for vasomotor symptoms of menopause,” said Christine Roth, Bayer’s executive vice president of global product strategy and commercialization, in a news release Friday. “There’s a growing need for personalized approaches to menopause care, and Lynkuet fills a crucial gap in treatment options.”

For many women, hormone therapy can be a safe and effective way to manage symptoms like hot flashes. However, some women with certain health conditions or a history of diseases, including specific cancers, are sometimes advised against hormone replacement therapy. In such cases, alternative options like Lynkuet may be particularly valuable.

<h2>Clinical Trial Shows Promising Results</h2>

A Phase 3 clinical trial involving 628 postmenopausal women found that those taking elinzanetant for 12 weeks saw more than a 73% reduction in the frequency of their vasomotor symptoms, compared with a 47% reduction in those who received a placebo. The most commonly reported side effects were drowsiness, fatigue, and headaches.

“This year-long study not only confirmed rapid and substantial relief from the frequency and severity of hot flashes and night sweats but also showed that these benefits lasted for a full year, offering hope for long-term symptom control,” said Dr. JoAnn Pinkerton, director of midlife health at UVA Health and emeritus executive director of the North American Menopause Society, when the trial results were published.

“For women facing moderate to severe vasomotor symptoms during menopause, treatment options have been limited, especially for those who cannot or prefer not to use hormone therapy,” Pinkerton added. “Severe hot flashes can disrupt daily life, work, and home routines, highlighting the need for effective non-hormonal treatments.”

Hot flashes are sudden, intense feelings of heat that usually affect the face, chest, and head. They can bring on heavy sweating and flushing for several minutes. Nighttime episodes are called night sweats. Women can experience hot flashes sporadically or multiple times a day, making them highly disruptive.

“It’s important that women know there are choices to treat moderate to severe hot flashes, and this approval gives healthcare providers another option,” said Claire Gill, president and founder of the National Menopause Foundation, in Bayer’s announcement.

<h2>A New Era of <span rel="noindex">Menopause Treatment</span></h2>

In 2023, the FDA approved another non-hormonal menopause drug, fezolinetant, which also provides an alternative to traditional hormone therapies for hot flashes. Fezolinetant and elinzanetant are among the first drugs to target a recently discovered brain pathway involved in regulating hot flashes.

During menopause, declining estrogen levels trigger overactive nerves in the hypothalamus, a small region deep in the brain that helps control the body’s thermostat. These nerves release too many chemical signals called neurokinins. Both drugs block neurokinin receptors on brain cells, reducing the signals that trigger hot flashes.

“Severe hot flashes can significantly affect daily life,” Pinkerton said. “This approval gives healthcare providers a new, first-line option to help women with moderate to severe menopause-related hot flashes.”

Health Conditions A-Z

health

new-fda-approved-medicine

lynkuet

non hormonal menopause treatment

menopause

hot flashes menopause

Menopause Treatment

nasas-artemis-ii-mission-to-test-human-health-in-deep-space

NASA’s Artemis II Mission To Test Human Health in Deep Space

bob-harrisbbcradio2-hosthospitalized-again-for-prostate-cancertreatment

Bob Harris: BBC Radio 2 Host Hospitalized For Prostate Cancer Treatment

vaping-becomes-major-nicotine-threat-among-children-under-5-in-us-warns-study

Vaping Becomes Major Nicotine Threat Among Children Under 5 in US, Warns Study

Health News

8 Sit-Up Variations to Strengthen Your Core and Build Stability

Benefits Of Ayurvedic Health Supplement Ashwagandha

9 Anti-Inflammatory Breakfast Options You Should Try

5 Foods You Should Avoid For PCOS, Says Gynecologist

Love Sitting With Your Legs Crossed? Here’s You Should Avoid It

6 Daily Foods That Are Secretly Increasing Your Calories

9 Brain Boosters You Should Do Everyday

Hip Exercises That Will Keep You Flexible As You Age

9 Leg Exercises Office Workers’ Should Do At Home

Benefits of Having Herbal Tea Every Morning

9 Daily Habits That Boost Your Brain Power

Lower-Body Exercises That Are Game-Changers

How Drinking Apple Cider Vinegar Helps You

Aging Myths You Should Never Believe

Superfoods That Support Your Gut Health

What Happens To Your Body When You Eat Instant Noodles Every Day?

Health Issues Premature Babies Often Face

Exercises Office Workers Should Do For Their Heart Health

Reasons Why You Should Add Raw Turmeric To Your Diet

Benefits Of Drinking Milk At Night: Why You Should Do It

Food That Provides Vitamin B12 Naturally In Your Diet

Surprising Health Benefits Of Fenugreek Seeds

9 Superfoods You Should Eat For Your Brain Health

What Does Mental Health Support Look Like At Work?

Long Stretches You Should Do To Unwind From Your Day

Colon Cancer In Young Adults: Early Symptoms You Should Know

Health Benefits Of Eating Dry Fruits Everyday

Are You At Risk For Fried Rice Syndrome?

These Tests Reveal How Well You Are Aging

Lower-Back Exercises You Should Do After A Long-Day's Work

Children’s Diet – What Kids Need To Eat For Immunity Building

Common Diabetes Myths That Could Hurt Your Health

Love Spicy Food? Here’s How It Affects Your Health

Superfood List: Veggies And Fruits You Must Have For Immunity

Foods People With IBS Should Avoid

Exercises To Improve Digestion

Easy Work Lunches You Can Make In The Morning

Hunger Vs Craving: Difference Explained In 60 seconds

These Things Can Cause Your Heart To Age Faster

High Carb Foods That Are Actually Healthy

The US Food and Drug Administration has given the green light to a new once-daily pill that works without hormones to ease moderate to severe hot flashes in menopausal women, Bayer announced Friday. The drug, called elinzanetant, will be available in the US starting in November under the brand name Lynkuet, according to Bayer. It works by targeting brain chemicals responsible for hot flashes and night sweats, medically referred to as vasomotor symptoms. Experts estimate that over 80% of women experience hot flashes during menopause.“This FDA approval marks a bold leap forward, our first non-hormonal treatment for vasomotor symptoms of menopause,” said Christine Roth, Bayer’s executive vice president of global product strategy and commercialization, in a news release Friday. “There’s a growing need for personalized approaches to menopause care, and Lynkuet fills a crucial gap in treatment options.”For many women, hormone therapy can be a safe and effective way to manage symptoms like hot flashes. However, some women with certain health conditions or a history of diseases, including specific cancers, are sometimes advised against hormone replacement therapy. In such cases, alternative options like Lynkuet may be particularly valuable.Clinical Trial Shows Promising ResultsA Phase 3 clinical trial involving 628 postmenopausal women found that those taking elinzanetant for 12 weeks saw more than a 73% reduction in the frequency of their vasomotor symptoms, compared with a 47% reduction in those who received a placebo. The most commonly reported side effects were drowsiness, fatigue, and headaches.“This year-long study not only confirmed rapid and substantial relief from the frequency and severity of hot flashes and night sweats but also showed that these benefits lasted for a full year, offering hope for long-term symptom control,” said Dr. JoAnn Pinkerton, director of midlife health at UVA Health and emeritus executive director of the North American Menopause Society, when the trial results were published.“For women facing moderate to severe vasomotor symptoms during menopause, treatment options have been limited, especially for those who cannot or prefer not to use hormone therapy,” Pinkerton added. “Severe hot flashes can disrupt daily life, work, and home routines, highlighting the need for effective non-hormonal treatments.”Hot Flashes and Night SweatsHot flashes are sudden, intense feelings of heat that usually affect the face, chest, and head. They can bring on heavy sweating and flushing for several minutes. Nighttime episodes are called night sweats. Women can experience hot flashes sporadically or multiple times a day, making them highly disruptive.“It’s important that women know there are choices to treat moderate to severe hot flashes, and this approval gives healthcare providers another option,” said Claire Gill, president and founder of the National Menopause Foundation, in Bayer’s announcement.A New Era of Menopause TreatmentIn 2023, the FDA approved another non-hormonal menopause drug, fezolinetant, which also provides an alternative to traditional hormone therapies for hot flashes. Fezolinetant and elinzanetant are among the first drugs to target a recently discovered brain pathway involved in regulating hot flashes.During menopause, declining estrogen levels trigger overactive nerves in the hypothalamus, a small region deep in the brain that helps control the body’s thermostat. These nerves release too many chemical signals called neurokinins. Both drugs block neurokinin receptors on brain cells, reducing the signals that trigger hot flashes.“Severe hot flashes can significantly affect daily life,” Pinkerton said. “This approval gives healthcare providers a new, first-line option to help women with moderate to severe menopause-related hot flashes.”

new fda approved medicine offers hormone-free relief from menopause sweats

About Us

Contact Us

Terms & Conditions

Privacy Policy

Company

Health and Me is a premium website with content written and curated to function as a handbook for all Health concerns.

New FDA Approved Medicine Offers Hormone-Free Relief From Menopause Sweats

NASA’s Artemis II Mission To Test Human Health in Deep Space

COVID Cicada Variant Unlikely To Pose Major Threat, Claims Study

India Passes Jan Vishwas Bill: Here’s How It Decriminalizes Health Sector, Boosts Compliance

Health Conditions A-Z

NASA’s Artemis II Mission To Test Human Health in Deep Space

Bob Harris: BBC Radio 2 Host Hospitalized For Prostate Cancer Treatment

Vaping Becomes Major Nicotine Threat Among Children Under 5 in US, Warns Study